Clinical Trial Update: The EASYTRAK EPI Clinical Investigation [NA]

View source ↗

Summary

The EASYTRAK EPI clinical investigation by Boston Scientific has completed and posted results for patients with bradycardia and congestive heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia
• Heart Failure

Drugs mentioned

• EASYTRAK EPI

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Bradycardia, Congestive Heart Failure | NA | Status: COMPLETED | Results posted: 2017-04-28